Literature DB >> 20538671

Diagnostic accuracy of myocardial perfusion imaging and stress echocardiography for the diagnosis of left main and triple vessel coronary artery disease: a comparative meta-analysis.

N Mahajan1, L Polavaram, H Vankayala, B Ference, Y Wang, J Ager, J Kovach, L Afonso.   

Abstract

OBJECTIVES: Compare the diagnostic performance of stress echocardiography (SE) and myocardial perfusion imaging (MPI) for the diagnosis of left main disease (LM) and triple vessel disease (TVD).
BACKGROUND: Limited comparative data on MPI and SE for the detection of LM and TVD (high-risk coronary artery disease) exist in the literature.
METHODS: Quantitative meta-analysis was performed using studies identified by systematic electronic literature search. Articles were included if they reported data on exercise, dobutamine SE or exercise, adenosine, dipyridamole, thallium201, technetium 99m sestamibi MPI and used coronary angiography as the reference test. Summary receiver-operating characteristic (SROC) curves were constructed for each imaging modality. Additionally, pooled sensitivity, specificity and likelihood ratios were calculated per modality. Meta-regression was performed to adjust for patient and study characteristics.
RESULTS: Thirty-two studies met inclusion criteria; 23 (MPI-15; SE-14; Common studies-6) provided sufficient data for analysis. In a SROC model comparing the two imaging modalities, SE was associated with higher area under curve (0.82 (0.03) vs 0.73 (0.02), p=0.01) and index Q* value (0.75 (0.02) vs 0.67 (0.02), p=0.01). Using pooled summary point estimates, SE had higher pooled sensitivity (94% vs 75%, p<0.001) and lower negative likelihood ratio (0.21 vs 0.47, p<0.001) compared to MPI. No evidence of a difference in the pooled specificity (40% vs 48%, p=0.16) and positive likelihood ratio (1.52 vs 1.58, p=0.36) was seen between the two stress modalities. Pooled diagnostic OR on meta-regression (9.78 vs 4.06, p=0.02) remained significantly higher for SE compared to MPI for identification of LM and TVD even after adjustment for study characteristics.
CONCLUSIONS: Since LM alone or in combination with TVD are categorised as representing potentially life-threatening variants of CAD, a screening test with high sensitivity, low negative likelihood ratio or higher discriminatory capacity would be desirable for risk stratification. In the absence of a direct head-to-head comparison of the diagnostic accuracies of SE and MPI, our findings indicate that SE appears to be the preferred screening modality for high-risk coronary artery disease.

Entities:  

Mesh:

Year:  2010        PMID: 20538671     DOI: 10.1136/hrt.2009.182295

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  26 in total

1.  Diagnostic performance of combined noninvasive coronary angiography and myocardial perfusion imaging using 320 row detector computed tomography: design and implementation of the CORE320 multicenter, multinational diagnostic study.

Authors:  Andrea L Vavere; Gregory G Simon; Richard T George; Carlos E Rochitte; Andrew E Arai; Julie M Miller; Marcello Di Carli; Armin Arbab-Zadeh; Armin A Zadeh; Marc Dewey; Hiroyuki Niinuma; Roger Laham; Frank J Rybicki; Joanne D Schuijf; Narinder Paul; John Hoe; Sachio Kuribyashi; Hajime Sakuma; Cesar Nomura; Tan Swee Yaw; Klaus F Kofoed; Kunihiro Yoshioka; Melvin E Clouse; Jeffrey Brinker; Christopher Cox; Joao A C Lima
Journal:  J Cardiovasc Comput Tomogr       Date:  2011-11-12

2.  From stenosis imaging to functional imaging: a new horizon of coronary computed tomography.

Authors:  Jin-Ho Choi; Yeon Hyeon Choe; James K Min
Journal:  Int J Cardiovasc Imaging       Date:  2010-11-23       Impact factor: 2.357

Review 3.  Left main coronary artery disease: A review of the spectrum of noninvasive diagnostic modalities.

Authors:  Nishtha Sareen; Karthik Ananthasubramaniam
Journal:  J Nucl Cardiol       Date:  2015-10-20       Impact factor: 5.952

4.  High-risk coronary artery disease, but normal myocardial perfusion: A matter of concern?

Authors:  Shu Yokota; Mohamed Mouden; Jan Paul Ottervanger
Journal:  J Nucl Cardiol       Date:  2015-05-21       Impact factor: 5.952

5.  Prognostic value of adenosine stress cardiovascular magnetic resonance and dobutamine stress echocardiography in patients with low-risk chest pain.

Authors:  Gregory Hartlage; Matthew Janik; Athanasios Anadiotis; Emir Veledar; John Oshinski; Dimitrios Kremastinos; Arthur Stillman; Stamatios Lerakis
Journal:  Int J Cardiovasc Imaging       Date:  2011-05-12       Impact factor: 2.357

6.  Fast myocardial perfusion imaging with 99mTc in challenging patients using conventional SPECT cameras.

Authors:  Athanasios Katsikis; Athanasios Theodorakos; Anna Kouzoumi; Elpida Kitziri; Evangelos Georgiou; Maria Koutelou
Journal:  J Nucl Cardiol       Date:  2016-03-14       Impact factor: 5.952

7.  Does ischemic burden on stress testing influence patient survival in subjects with known severe multi-vessel CAD?

Authors:  Shey Mukundan; Mark I Travin; Jeffrey M Levsky; Matthew P Liakos; Daniel M Spevack
Journal:  Am J Cardiovasc Dis       Date:  2017-04-15

Review 8.  Finding the Gatekeeper to the Cardiac Catheterization Laboratory: Coronary CT Angiography or Stress Testing?

Authors:  Thomas H Marwick; Iksung Cho; Bríain Ó Hartaigh; James K Min
Journal:  J Am Coll Cardiol       Date:  2015-06-30       Impact factor: 24.094

9.  Improved diagnosis of the number of stenosed coronary artery vessels by segmentation with scatter and photo-peak window data for attenuation correction in myocardial perfusion SPECT.

Authors:  Yohei Yamauchi; Yumiko Kanzaki; Masuo Hayashi; Mami Arai; Hideaki Morita; Tsuyoshi Komori; Masaaki Hoshiga; Nobukazu Ishizaka
Journal:  J Nucl Cardiol       Date:  2017-09-13       Impact factor: 5.952

10.  Diagnostic performance of computed tomography coronary angiography to detect and exclude left main and/or three-vessel coronary artery disease.

Authors:  Anoeshka S Dharampal; Stella L Papadopoulou; Alexia Rossi; W Bob Meijboom; Annick Weustink; Marcel Dijkshoorn; Koen Nieman; Eric H Boersma; Pim J de Feijter; Gabriel P Krestin
Journal:  Eur Radiol       Date:  2013-06-28       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.